International Stem Cell Corp. (ISCO)

[GForbid]

Yes, dilution is surely one of the issues that affects the stock price majorly for EPS. (In the case of ISCO, based on Q1 2014 Earning Report, EPS was - $0.01, and now with new shares diluted, EPS is - $0.02. In this type of development stage biotech companies, - $0.01 and - $0.02 are not even making any difference. Hypothetically, let's say, APPLE dilutes it shares by double, do you think its stock price will go down like this? I do not think so.) The fundamental problem with ISCO stock price is not about share dilution. It is, as I have been saying over and over, about lack of market recognition and promotion, and cheap-sellings of day-traders (Day-traders, by their nature as we know, do not care about the company's book value or EPS as long as they can make money daily that ISCO is a very good stock as it goes up and down anywhere from 3% ~ 10% on daily base). The way I see the whole situation is that some good articles from the reputable stock analysts will simply turn everything around. I bet ISCO itself is also wondering why its stock price is staying low like this not knowing what they are not doing correctly (promotion part). Probably, they don't have the urgency in promoting because their subsidiaries are making enough money that they can simply dilute shares to raise more fund to offset their fund requirement. I long ISCO waiting for the moment of PPS hits its fair market value of +/- $0.70.